Notes: This data is based on lobbying disclosure filings and, as such, provides a lagging and at times incomplete account of lobbying activity. What’s more, it captures only lobbying that takes place at the federal level, meaning state-level efforts are not reflected here. Please also note that filings must only specify the approximate amount spent where it exceeds $5,000. Otherwise, a $0 figure may be reported. ∎
Federal Lobbying by Psychedelic Drug Developers
Federal Lobbying by Psychedelic Non-Profits
Overview of Federal Psychedelic Lobbying Spend
Pα+ delivers the policy intelligence serious stakeholders rely on. Get in-depth coverage of psychedelic policy and regulation—tracking developments from Capitol Hill to state legislatures. With expert analysis and curated insights, Pα+ keeps you informed on the decisions shaping the future of psychedelics. Subscribe today.